RPL22L1 and prostate adenocarcinoma: RPL22L1 demonstrates prognostic significance in kidney renal clear cell carcinoma (KIRC), emerges as a key gene in the progression of prostate cancer (PRAD), and may serve as a potential target for therapeutic interventions in PRAD [9–11].